Gonzalez David Angulo - Feb 4, 2022 Form 4 Insider Report for SCYNEXIS INC (SCYX)

Role
Chief Medical Officer
Signature
/s/ Robert F. Joyce Jr., by Power of Attorney
Stock symbol
SCYX
Transactions as of
Feb 4, 2022
Transactions value $
$0
Form type
4
Date filed
2/8/2022, 03:11 PM
Next filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCYX Common Stock Award $0 +51.1K +213.98% $0.00 75K Feb 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCYX Stock Option (Right to Buy) Award $0 +85K $0.00 85K Feb 4, 2022 Common Stock 85K $4.60 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 50% per year over two years on the anniversary of the date of grant.
F2 1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant.